logical respiration. The aim of this study is to evaluate the percentage of decannulation with respect to different or multiple surgical treatments. METHOD: We retrospectively reviewed the charts of 70 patients, 39 males and 31 females with an average age of 52.6 years treated between 1990 and 2005 for LS of various etiologies: iatrogenic stenosis (53 cases), post-traumatic stenosis (11 cases), other causes (autoimmune disease: 3, laryngeal papillomatosis: 2, diphtheria: 1). In order to maintain laryngeal patency, a Montgomery safe T-tube was used in all patients as unique dilation treatment or was associated with endoscopic and/or open-neck surgery. A total of 349 surgical interventions have been performed. RESULTS: 54/70 patients (77.1%) were ultimately decannulated, 39 of these (72.2%) underwent 3 or less surgical procedures, showing a significant difference compared to patients who underwent more than 3 surgeries (p:0.00002). Only 7/54 patients (12.9%) were decannulated after more than 5 surgical procedures. Patients over 60 years of age showed a significantly lower success rate (p:0.0017). There is no significant correlation between the rate of decannulation and gender, etiology, site of stenosis or surgery. CONCLUSION: Patients undergoing dilation for LS usually require multiple procedures. The T-tube plays an important role in the treatment of this pathology. However, if the tracheostomy is not removed within 3 surgical interventions, the odds of decannulating the patients decrease significantly and additional surgeries could represent therapeutic relentlessness.
Nasolabial Flap Reconstruction of the Lip in Rhinectomy
Joseph Hall, MD (presenter); Sarah Rohde, MD; James Netterville, MD OBJECTIVE: To describe the role of bilateral superiorly based nasolabial flaps in reconstruction after partial lip resection in conjunction with total rhinectomy. METHOD: A retrospective chart review was performed for patients undergoing total rhinectomy by the senior author at a tertiary care institution from 1997 to 2009. RESULTS: Twenty-four patients were identified. Seventeen underwent total rhinectomy without need for lip reconstruction. Two had larger lip, cheek and bone defects requiring free flap reconstruction. The remaining five patients (20.8%) had significant loss of vertical lip height reconstructed with bilateral superiorly based nasolabial flaps. All of these patients were male with an average age of 59 years. Three patients (60%) had pre-operative external beam radiation, while the other two patients (40%) required post-operative radiation therapy. Two of the five patients (40%) had a history of nasal tumor resections. A fistula at the nasolabial flap site in a patient with pre-operative radiation treatment was the only complication. The average height added to the upper lip was two centimeters. All patients maintained upper lip length and oral competence. All five patients were then successfully reconstructed using a total nasal prosthesis, with an average time to prosthesis of 5.75 months. CONCLUSION: Significant upper lip height deficits accompany total rhinectomy in a large percentage of patients. Bilateral superiorly based nasolabial flaps are an invaluable source of local tissue for upper lip reconstruction to maintain both lip height and oral competence.
Nimesulide Suppresses the Malignant Potential of FaDu Cells
Jiajun Tian, MD (presenter); Wei Xu, MD, PhD; Haibo Wang, MD OBJECTIVE: In present study, we aimed to investigate the effect of Nimesulide, a selective COX-2 inhibitor, on the malignant potential of human hypopharyngeal carcinoma cell line (FaDu).
METHOD: Morphological changes of FaDu cells in response
to Nimesulide were observed by reserved microscopy and acridine orange cytochemistry staining. Viability of cells treated with various concentrations of Nimesulide was quantified by 3-(4, 5-dimethyl-thiazol-2yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. Proliferating cells were detected using the 5-Bromo-2-deoxy-uridine (BrdU) incorporation assay. The ability of invasion and migration of cells were detected by Transwell Chambers. When cells were subjected to Nimesulide (500 mol/l) for 6 h and 12 h, the expression of COX-2 was determined by Western blot, expressions of matrix metalloproteinase-9 (MMP-9) and Caspase-3 at mRNA and protein levels were analyzed by reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot. RESULTS: The viability of FaDu cells was suppressed by Nimesulide in time-and dose-dependent manner, which was further revealed to inhibit proliferation and to trigger apoptotic pathway. Nimesulide also inhibited the invasion and migration of FaDu cells. All these inhibitory effects of Nimesulide may be associated with decreased expression of COX-2 and MMP-9, and induced cleavage activation of Caspase-3. CONCLUSION: The current work demonstrates that Nimesulide possesses the antitumor effects on FaDu cells, which may represent a useful therapeutic strategy for the treatment of human hypopharyngeal carcinoma.
Nonvestibular Schwannomas of the Head and Neck
Alper Ceylan, MD (presenter); Fatih Celenk, MD; Metin Yilmaz, MD; Ozan Gokdogan, MD; Erdogan Inal, MD OBJECTIVE: To assess the clinical presentation, location, nerve of origin, diagnosis and treatment of the nonvestibular head and neck schwannomas.
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